Single or double consolidation treatment according to remission status after initial therapy in metastatic neuroblastoma: first results of LMCE 3 study in 40 patients.
Zucker
J M
JM
Pediatric oncology department, Institut Curie, Paris, France.
Philip
T
T
Bernard
J L
JL
Michon
J
J
Bouffet
E
E
Gentet
J C
JC
Lopez
M
M
Coze
C
C
Philip
I
I
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000379:methods* / Q000401:mortality; D016190:Carboplatin / Q000008:administration & dosage; D002330:Carmustine / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D007223:Infant; D015993:Life Tables; D008297:Male; D009447:Neuroblastoma / Q000188:drug therapy / Q000401:mortality / Q000556:secondary* / Q000601:surgery; D012074:Remission Induction; D012086:Reoperation; D016019:Survival Analysis; D014182:Transplantation, Autologous; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D016190:Carboplatin; D002945:Cisplatin; D002330:Carmustine